Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Medicinova 2025 10-K: Revenue $0.41M, EPS $(0.24)
Medicinova reported $0.41 million in revenue for the year ended December 31, 2025, primarily from a Mayo clinical services agreement, and a net loss per common share of $(0.24). The company’s net loss was $(12.00) million and operating loss was $(13.28) million, attributed to continued investment in R&D and general corporate expenses. Medicinova is advancing clinical programs for MN-166 and MN-001 and has secured capital access through a structured equity purchase agreement and an at-the-market facility to support operations into 2026.